A dramatic twist is unfolding in the high-profile murder case that shocked the nation. Luigi Mangione, the 28-year-old accused of gunning down UnitedHealthcare CEO Brian Thompson in cold blood, is reportedly set to plead guilty in federal court this Friday, according to sources close to the matter.
The Ivy League grad, who once seemed destined for a life of privilege, now faces a potential life sentence—but his legal team is reportedly hoping a guilty plea will convince the judge to hand down a lighter punishment. Sources caution that Mangione could still change his mind at any moment, even during Friday’s hearing in Manhattan federal court.
The federal charges against him include two counts of stalking resulting in death, tied to the alleged December 2024 assassination on a Manhattan sidewalk. Two other counts, including one that could have carried the death penalty, were previously tossed by a judge due to what were described as “legal infirmities.”
If a deal goes through, it could seriously complicate a separate state case set for trial on September 8. New York’s double jeopardy rules might prevent prosecutors from trying him again for the same crime. However, the Manhattan District Attorney’s Office, which claims primary jurisdiction, could still push for a state trial if they don’t like the terms of any federal plea.
The case has already captivated the public, from the dramatic five-day manhunt that ended with Mangione eating breakfast at a Pennsylvania McDonald’s, to the chilling details left at the crime scene—bullet casings reportedly etched with the words “delay” and “deny,” a phrase critics say insurers use to avoid paying claims.
If no plea is reached, the federal trial is tentatively set for early 2027. But with Friday’s hearing looming, the question on everyone’s mind is: will Mangione take the deal, or gamble on a jury?
